These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

835 related items for PubMed ID: 7506671

  • 1. Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE, Benninger L, Patel SR, Benjamin RS, Vadhan-Raj S.
    Exp Hematol; 1994 Jan; 22(1):100-2. PubMed ID: 7506671
    [Abstract] [Full Text] [Related]

  • 2. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE, Benninger L, Cooper S, Hague N, Benjamin RS, Vadhan-Raj S.
    Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
    [Abstract] [Full Text] [Related]

  • 3. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 4. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW, Li F, Pettit GR, Grant S.
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [Abstract] [Full Text] [Related]

  • 5. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.
    Ottmann OG, Abboud M, Welte K, Souza LM, Pelus LM.
    Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933
    [Abstract] [Full Text] [Related]

  • 6. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM, Gulati SC.
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [Abstract] [Full Text] [Related]

  • 7. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
    Tanikawa S, Nakao I, Tsuneoka K, Nara N.
    Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360
    [Abstract] [Full Text] [Related]

  • 8. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K, Inoue S, Kumar A.
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [Abstract] [Full Text] [Related]

  • 9. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S.
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [Abstract] [Full Text] [Related]

  • 10. Mechanism of synergy between granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in colony formation from human marrow cells in vitro.
    Hara H, Namiki M.
    Exp Hematol; 1989 Aug; 17(7):816-21. PubMed ID: 2473914
    [Abstract] [Full Text] [Related]

  • 11. Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia.
    Estrov Z, Estey EH, Andreeff M, Talpaz M, Kurzrock R, Reading CL, Deisseroth AB, Gutterman JU.
    Exp Hematol; 1992 Jun; 20(5):558-64. PubMed ID: 1587302
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
    Brandwein JM, Nayar R, Baker MA, Sutton DM, Scott JG, Sutcliffe SB, Keating A.
    Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
    [Abstract] [Full Text] [Related]

  • 17. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Gibson FM, Scopes J, Daly S, Ball SE, Gordon-Smith EC.
    Exp Hematol; 1994 Mar; 22(3):302-12. PubMed ID: 8112428
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Granulocyte-macrophage colony stimulating factor and interleukin 3: target cells and kinetics of response in vivo.
    Aglietta M, Pasquino P, Sanavio F, Stacchini A, Severino A, Fubini L, Morelli S, Volta C, Monteverde A, Piacibello W.
    Stem Cells; 1993 Jul; 11 Suppl 2():83-7. PubMed ID: 8401260
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.